Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
2.58
-0.01 (-0.39%)
At close: Jun 27, 2025, 11:22 AM
-0.39% (1D)
| Bid | 2.58 |
| Market Cap | 278.5M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -258.03M |
| EPS (ttm) | -2.63 |
| PE Ratio (ttm) | -0.98 |
| Forward PE | -1.55 |
| Analyst | Buy |
| Ask | 2.59 |
| Volume | 890,659 |
| Avg. Volume (20D) | 5,214,811 |
| Open | 2.58 |
| Previous Close | 2.59 |
| Day's Range | 2.56 - 2.69 |
| 52-Week Range | 2.19 - 26.98 |
| Beta | 0.68 |
About RCKT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RCKT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RCKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Rocket Pharmaceuticals Inc. is scheduled to release its earnings on Aug 4, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-62.84%
Rocket Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
1 month ago
+11.06%
Rocket Pharmaceuticals shares are trading higher after the company presented preliminary data from its Phase 1 trial of RP-A601.
